MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karras, J. G.
Right arrow Articles by Monia, B. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karras, J. G.
Right arrow Articles by Monia, B. P.

Vol. 58, Issue 2, 380-387, August 2000

Deletion of Individual Exons and Induction of Soluble Murine Interleukin-5 Receptor-alpha Chain Expression through Antisense Oligonucleotide-Mediated Redirection of Pre-mRNA Splicing

James G. Karras, Robert A. McKay, Nicholas M. Dean, and Brett P. Monia

Departments of Molecular and Cellular Pharmacology (J.G.K., R.A.M., B.P.M.) and Pharmacology (N.M.D.), ISIS Pharmaceuticals, Carlsbad, California

Expression of the interleukin-5 receptor-alpha (IL-5Ralpha ) chain is thought to play an important role in the pathogenesis of asthma and other eosinophilic diseases. With antisense oligonucleotides (ASOs) chemically modified to provide increased hybridization affinity for RNA but that do not support RNase H-mediated cleavage (2'-O-methoxyethyl-modified ASOs), we show that constitutive splicing of murine IL-5Ralpha mRNA can be modulated in cells such that individual exons may be selectively deleted from mature transcripts. Specific deletion of individual exons and redirection of alternative splicing of the IL-5Ralpha mRNA have been achieved with this approach, by targeting 3'-splice sites or exon sequences immediately downstream of an alternative splice site. ASO targeting with these strategies resulted in inhibition of mRNA and protein levels of the membrane IL-5Ralpha isoform capable of signaling IL-5-mediated growth and antiapoptotic signals to eosinophils. Membrane isoform IL-5Ralpha inhibition was coupled with an increase in expression of mRNA for the alternatively spliced soluble isoform, which binds IL-5 extracellularly and may block its function. These observations suggest the potential general therapeutic use of an antisense approach to increase expression of variant RNA transcripts and to thereby produce proteins devoid of specific functional domains that may impact disease processes, as well as its specific utility for modulating expression of a key cytokine receptor implicated in allergic inflammation.

Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 RNAHome page
A. Aartsma-Rus and G.-J. B. van Ommen
Antisense-mediated exon skipping: A versatile tool with therapeutic and research applications
RNA, October 1, 2007; 13(10): 1609 - 1624.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. A. Vickers, H. Zhang, M. J. Graham, K. M. Lemonidis, C. Zhao, and N. M. Dean
Modification of MyD88 mRNA Splicing and Inhibition of IL-1beta Signaling in Cell Culture and in Mice with a 2'-O-Methoxyethyl-Modified Oligonucleotide
J. Immunol., March 15, 2006; 176(6): 3652 - 3661.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
A. J. Tyson-Capper and G. N. Europe-Finner
Novel Targeting of Cyclooxygenase-2 (COX-2) Pre-mRNA Using Antisense Morpholino Oligonucleotides Directed to the 3' Acceptor and 5' Donor Splice Sites of Exon 4: Suppression of COX-2 Activity in Human Amnion-Derived WISH and Myometrial Cells
Mol. Pharmacol., March 1, 2006; 69(3): 796 - 804.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
X. Liu, K. Nakamura, Y. Wang, Y. Wang, G. Liu, J. He, H. Ding, P. Lu, M. Rusckowski, A. Kubo, et al.
Initial Mechanistic Studies of Antisense Targeting in Cells
J. Nucl. Med., February 1, 2006; 47(2): 360 - 368.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
D. Ittig, S. Liu, D. Renneberg, D. Schumperli, and C. J. Leumann
Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA
Nucleic Acids Res., January 15, 2004; 32(1): 346 - 353.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
P. Sazani, S.-H. Kang, M. A. Maier, C. Wei, J. Dillman, J. Summerton, M. Manoharan, and R. Kole
Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs
Nucleic Acids Res., October 1, 2001; 29(19): 3965 - 3974.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Liu, L. Li, P. E. Nisson, C. Gruber, J. Jessee, and S. N. Cohen
Neoplastic Transformation and Tumorigenesis Associated with Sam68 Protein Deficiency in Cultured Murine Fibroblasts
J. Biol. Chem., December 15, 2000; 275(51): 40195 - 40201.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics